Identification and characterization of an endogenous chemotactic ligand specific for FPRL2


Chemotaxis of dendritic cells (DCs) and monocytes is a key step in the initiation of an adequate immune response. Formyl peptide receptor (FPR) and FPR-like receptor (FPRL)1, two G protein-coupled receptors belonging to the FPR family, play an essential role in host defense mechanisms against bacterial infection and in the regulation of inflammatory reactions. FPRL2, the third member of this structural family of chemoattractant receptors, is characterized by its specific expression on monocytes and DCs. Here, we present the isolation from a spleen extract and the functional characterization of F2L, a novel chemoattractant peptide acting specifically through FPRL2. F2L is an acetylated amino-terminal peptide derived from the cleavage of the human heme-binding protein, an intracellular tetrapyrolle-binding protein. The peptide binds and activates FPRL2 in the low nanomolar range, which triggers intracellular calcium release, inhibition of cAMP accumulation, and phosphorylation of extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases through the G(i) class of heterotrimeric G proteins. When tested on monocytes and monocyte-derived DCs, F2L promotes calcium mobilization and chemotaxis. Therefore, F2L appears as a new natural chemoattractant peptide for DCs and monocytes, and the first potent and specific agonist of FPRL2.

Extracted Key Phrases

6 Figures and Tables

Citations per Year

275 Citations

Semantic Scholar estimates that this publication has 275 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Migeotte2005IdentificationAC, title={Identification and characterization of an endogenous chemotactic ligand specific for FPRL2}, author={Isabelle Migeotte and Elena Riboldi and J D F Franssen and Françoise Gr{\'e}goire and C{\'e}cile Loison and Valērie Wittamer and Michel Detheux and Patrick Robberecht and Sabine Costagliola and G. Vassart and Silvano Sozzani and Marc Parmentier and David Communi}, journal={The Journal of Experimental Medicine}, year={2005}, volume={201}, pages={83 - 93} }